Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cyclopenthiazide (trade name Navidrex) is a thiazide diuretic used in the treatment of heart failure and hypertension.
The analysis highlights Art, Contraindications and Overview as prominent areas in the source structure around Cyclopenthiazide.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Cyclopenthiazide shows recurring relationship patterns in the source. For example, Cyclopenthiazide → Interactive image Another extracted example is Cyclopenthiazide → International Drug Names. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
name thiazide also diuretic contraindicated patients trade navidrex used treatment heart failure hypertension synthesis contraindications see references
TTTA extracted 15 structured relationships around Cyclopenthiazide. Examples in this analysis include Cyclopenthiazide → 3D model (JSmol) → Interactive image and Cyclopenthiazide → AHFS/Drugs.com → International Drug Names. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cyclopenthiazide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cyclopenthiazide | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Cyclopenthiazide | ATC code | C03AA07 (WHO) | 1.00 | infobox |
| Cyclopenthiazide | CAS Number | 742-20-1 | 1.00 | infobox |
| Cyclopenthiazide | ChEMBL | ChEMBL1373254 | 1.00 | infobox |
| Cyclopenthiazide | ChemSpider | 2801 | 1.00 | infobox |
| Cyclopenthiazide | CompTox Dashboard (EPA) | DTXSID4022868 | 1.00 | infobox |
| Cyclopenthiazide | ECHA InfoCard | 100.010.920 | 1.00 | infobox |
| Cyclopenthiazide | Formula | C13H18ClN3O4S2 | 1.00 | infobox |
| Cyclopenthiazide | IUPHAR/BPS | 7899 | 1.00 | infobox |
| Cyclopenthiazide | KEGG | D02061 Y | 1.00 | infobox |
| Cyclopenthiazide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Cyclopenthiazide | Molar mass | 379.87 g·mol−1 | 1.00 | infobox |
| Cyclopenthiazide | PubChem CID | 2904 | 1.00 | infobox |
| Cyclopenthiazide | UNII | VX4S2N85F5 | 1.00 | infobox |
The concept neighborhoods around Cyclopenthiazide bring nearby vocabulary together. In this analysis, examples include Name, Thiazide and Contraindications. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Cyclopenthiazide, one of the stronger structural bridges in this analysis connects Cyclopenthiazide with Contraindications. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Cyclopenthiazide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Art, Contraindications & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Cyclopenthiazide · EN edition · Analysis: TopicsToTalkAbout